What is Seaport Therapeutics 's investment proceeds?

Seaport Therapeutics (SPTX) reported investment proceeds of $75M in Q1 2026.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Seaport Therapeutics SPTX Investment Proceeds

Investment Proceeds at other companies

RepligenRGEN

$66M—

AppFolioAPPF

$140.15M+36.4%

Gates Industrial CorporationGTES

$0-100%

Granite ConstructionGVA

$39M+449%

DiodesDIOD

$0-100%

Clearwater AnalyticsCWAN

$0-100%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's investment proceeds?: Seaport Therapeutics (SPTX) reported investment proceeds of $75M in Q1 2026.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.